Search Clinical Trials
583,695 trials
ID
Status
Phase
Title
Sponsor
NCT07575880
Screening for Obstructive Respiratory Disorders in the General Population During the "Mai Poumon 2026" Prevention Campaign: Prevalence and Impact on the Care PathwayCentre Hospitalier de la côte BasqueNot Yet Recruiting
NCT07575880Not Yet Recruiting
—
Screening for Obstructive Respiratory Disorders in the General Population During...Centre Hospitalier de la...
NCT07575191
Safety and Performance of a Novel Infusion Catheter System for Peri/Intratumoral Gemcitabine Delivery in Patients With Pancreatic CancerSmartwise Sweden ABNot Yet RecruitingPhase 1
NCT07575191Not Yet Recruiting
Phase 1
Safety and Performance of a Novel Infusion Catheter System for Peri/Intratumoral...Smartwise Sweden AB
NCT07576257
OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosili-cate in Heart Failure -Extension (OPRA-HF Extension)Sahlgrenska University HospitalNot Yet RecruitingPhase 2
NCT07576257Not Yet Recruiting
Phase 2
OPtimizing Aldosterone Receptor Antagonist Therapy by Sodium Zirconium Cyclosili...Sahlgrenska University Ho...
NCT07575906
A Study to Learn How a Single Dose of the Study Medicine Called PF-08057418 is Tolerated in the Body of Healthy Adults.PfizerNot Yet RecruitingPhase 1
NCT07575906Not Yet Recruiting
Phase 1
A Study to Learn How a Single Dose of the Study Medicine Called PF-08057418 is T...Pfizer
NCT07576036
International Multi-center Retrospective Study of Patients With Serum Sodium ≤110 mmol/L to Determine the Relationship Between Osmotic Demyelination Syndrome (ODS) and Rapid Correction of HyponatremiaRochester General HospitalEnrolling By Invitation
NCT07576036Enrolling By Invitation
—
International Multi-center Retrospective Study of Patients With Serum Sodium ≤11...Rochester General Hospita...
NCT07574827
Candida Albicans in Syrian Patients With PeriodontitisAl-Hawash Private UniversityRecruiting
NCT07574827Recruiting
—
Candida Albicans in Syrian Patients With PeriodontitisAl-Hawash Private Univers...
NCT07576764
Pediatric Prolonged-Release Melatonin for Sleep Disturbances in Children and Adolescents With Anorexia Nervosa (MELSom-ANOREXIA)Assistance Publique Hopitaux De MarseilleNot Yet RecruitingPhase 3
NCT07576764Not Yet Recruiting
Phase 3
Pediatric Prolonged-Release Melatonin for Sleep Disturbances in Children and Ado...Assistance Publique Hopit...
NCT07574710
Effects of Implant Placement Depth (4 mm Versus 6 mm) on Crestal Bone Stability in Immediate Implant Placement: A Clinical Study With 1-Year Post-Restorative ResultsTomas LinkeviciusCompletedNot Applicable
NCT07574710Completed
Not Applicable
Effects of Implant Placement Depth (4 mm Versus 6 mm) on Crestal Bone Stability...Tomas Linkevicius
NCT07574944
Effectiveness of Simulation-based Training Delivered to Special Newborn Care Providers on Resuscitation Management and Kangaroo Mother Care: Simulation-based Training for Asyphxia in Babies Trial (STAR-Baby Trial)Development and Research Service International NepalNot Yet RecruitingNot Applicable
NCT07574944Not Yet Recruiting
Not Applicable
Effectiveness of Simulation-based Training Delivered to Special Newborn Care Pro...Development and Research...
NCT07576673
Self-Cure vs. Highly Filled Flowable Composite in Carious Cervical Lesions: 18-Month RCTCairo UniversityNot Yet RecruitingNot Applicable
NCT07576673Not Yet Recruiting
Not Applicable
Self-Cure vs. Highly Filled Flowable Composite in Carious Cervical Lesions: 18-M...Cairo University
NCT07575113
Comparison of Otago and Beat it Program on Balance, Gait and QOL in Diabetic NeuropathyRiphah International UniversityNot Yet RecruitingNot Applicable
NCT07575113Not Yet Recruiting
Not Applicable
Comparison of Otago and Beat it Program on Balance, Gait and QOL in Diabetic Neu...Riphah International Univ...
NCT07576972
Human Milk Concentrating Device to Optimize Mother's Own MilkBeth Israel Deaconess Medical CenterNot Yet RecruitingNot Applicable
NCT07576972Not Yet Recruiting
Not Applicable
Human Milk Concentrating Device to Optimize Mother's Own MilkBeth Israel Deaconess Med...
NCT07576049
COLORECTAL CANCER: SINGLE CENTER EXPERIENCEUniversity of Roma La SapienzaEnrolling By Invitation
NCT07576049Enrolling By Invitation
—
COLORECTAL CANCER: SINGLE CENTER EXPERIENCEUniversity of Roma La Sap...
NCT07575646
Clinical Evaluation of Self-Adhesive Flowable Giomer With and Without Selective Enamel EtchingCairo UniversityNot Yet RecruitingNot Applicable
NCT07575646Not Yet Recruiting
Not Applicable
Clinical Evaluation of Self-Adhesive Flowable Giomer With and Without Selective...Cairo University
NCT07576998
PHIL™ Middle Meningeal Artery Embolization for First-Line Treatment of Chronic Subdural Hematoma IDE TrialMicrovention-Terumo, Inc.Not Yet RecruitingNot Applicable
NCT07576998Not Yet Recruiting
Not Applicable
PHIL™ Middle Meningeal Artery Embolization for First-Line Treatment of Chronic S...Microvention-Terumo, Inc.
NCT07574554
Fixation of Mandibular Angle Fracture Using 3D Titanium Miniplate Versus Standard Two Plate FixationCairo UniversityActive Not RecruitingNot Applicable
NCT07574554Active Not Recruiting
Not Applicable
Fixation of Mandibular Angle Fracture Using 3D Titanium Miniplate Versus Standar...Cairo University
NCT07576842
Testing the Feasibility of Different HPV Screening and Care Strategies for Women Living With HIVBeth Israel Deaconess Medical CenterNot Yet RecruitingNot Applicable
NCT07576842Not Yet Recruiting
Not Applicable
Testing the Feasibility of Different HPV Screening and Care Strategies for Women...Beth Israel Deaconess Med...
NCT07576361
Impact of Microbiome in Endometriosis DevelopmentCentre Hospitalier Universitaire de la GuadeloupeCompleted
NCT07576621
Association Between Hypomagnesemia and Coagulopathy in SepsisAin Shams UniversityCompleted
NCT07576621Completed
—
Association Between Hypomagnesemia and Coagulopathy in SepsisAin Shams University
Result Breakdown
Not yet recruiting12 (60%)
Completed3 (15%)
Enrolling by invitation2 (10%)
Recruiting2 (10%)
Active, not recruiting1 (5%)
not_applicable10 (50%)
Not Specified6 (30%)
Phase 12 (10%)
Phase 21 (5%)
Phase 31 (5%)